valproic acid has been researched along with Carcinoma, Ductal, Pancreatic in 3 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mattheolabakis, G | 1 |
Wang, R | 1 |
Rigas, B | 1 |
Mackenzie, GG | 1 |
Fritsche, P | 2 |
Seidler, B | 1 |
Schüler, S | 2 |
Schnieke, A | 1 |
Göttlicher, M | 1 |
Schmid, RM | 2 |
Saur, D | 2 |
Schneider, G | 2 |
Diersch, S | 1 |
Arlt, A | 1 |
3 other studies available for valproic acid and Carcinoma, Ductal, Pancreatic
Article | Year |
---|---|
Phospho-valproic acid inhibits pancreatic cancer growth in mice: enhanced efficacy by its formulation in poly-(L)-lactic acid-poly(ethylene glycol) nanoparticles.
Topics: Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Female; Humans; Lact | 2017 |
HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; DNA Damage; Drug | 2009 |
HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells.
Topics: Apoptosis; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Enzyme Inhibitors; Gen | 2010 |